SenesTech, Inc. (SNES) Stock: A Biotechnology Stock That’s Seeing Gains


SenesTech, Inc. (SNES) is trending up in the market in today’s trading session. The stock, focused on the biotechnology industry, is currently priced at $1.12 after gaining 12.51% so far today. In terms of biotechnology stocks, there are quite a few aspects that have the potential to lead to gains in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines surrounding SNES:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-20-19 12:04PM What Kind Of Shareholder Appears On The SenesTech, Inc.’s (NASDAQ:SNES) Shareholder Register?
Aug-13-19 04:05PM SenesTech Announces Second Quarter 2019 Financial and Operational Results
07:50AM SenesTech’s Earnings Outlook
Aug-05-19 04:05PM 7 Stocks the Insiders Are Buying on Sale
Aug-01-19 09:00AM SenesTech, Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019

Nonetheless, any time investors are making a decision to invest, prospective investors should take a look at far more than news, especially in the generally speculative biotechnology sector. Here’s what’s happening in regard to SenesTech, Inc..

Recent Trends From SNES

Although a single session gain, like the move that we’re seeing from SenesTech, Inc. may make some investors happy, a single session gain alone shouldn’t be the basis of a decision to, or not to, invest in a stock. It’s always smart to take a look at trends experienced by the stock further out than a single session. As it relates to SNES, below are the movements that we have seen:

  • Past 5 Trading Sessions – Over the past five trading sessions, SNES has seen a change in value in the amount of -18.25%.
  • Past Month – The return from SenesTech, Inc. over the last month comes to -15.79%.
  • Past Quarter – Throughout the last quarter, the company has generated a ROI of -28.66%
  • Past 6 Months – Throughout the previous six months, we have seen a change that works out to 23.08% from the company.
  • Year To Date – Since the open of this year SNES has resulted in a ROI of 91.39%.
  • Full Year – Finally, throughout the last full year, investors have seen movement that comes to 37.81% out of SNES. In this period, the stock has sold at a high price of -42.56% and a low price of 103.64%.

Ratios Worth Paying Attention To

Digging into various ratios having to do with a stock generally gives investors a view of how dangerous and/or potentially profitable a stock pick might be. Below are some of the key ratios to look at when looking at SNES.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the value of the stock is going to go down. In general, biotechnology stocks can carry a higher short ratio. However, we also see a lot of short squeezes in the sector. Nonetheless, in relation to SenesTech, Inc., the stock’s short ratio is 9.55.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Basically, they measure the company’s abilities to cover its debts when they mature based on current assets or quick assets. In the biotechnology sector, many companies are reliant on continued support from investors, the current and quick ratios can seem bad. However, several good picks in the biotechnology space do have good current and quick ratios. In terms of SNES, the quick and current ratios come to 2.60 and 3.70 respectively.  

Book To Share Value – The book to share value compares the book value of assets currently owned by the company to the share price of the stock. when it comes to SenesTech, Inc., that ratio comes in at 0.16.

Cash To Share Value – Finally, the cash to share value comparison compares the total amount of cash the company has on hand to the value of shares. Several early stage biotech companies have a hard time keeping cash on hand. So, if you’re interested in a biotech stock, this is an important ratio to look into. In the case of SNES, the cash to share value works out to 0.

What Analysts Think About SenesTech, Inc.

Although it’s not a smart idea to blindly follow the opinions of analysts, it is a smart idea to consider their thoughts to validate your own due diligence when it comes to making investment decisions in the biotech sector. Here are the recent moves that we have seen from analysts as it relates to SNES.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Institutions And Insiders Think Of SenesTech, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in SNES, here’s what we’re seeing:

Institutions own 7.60% of the company. Institutional interest has moved by 4.88% over the past three months. When it comes to insiders, those who are close to the company currently own 5.30% percent of SNES shares. Institutions have seen ownership changes of an accumulative 75.30% over the last three months.

What’s Going On With Share Counts?

Traders and investors tend to be interested in the amounts of shares both outstanding and available. In regard to SenesTech, Inc., currently there are 25.18M and there is a float of 25.18M. These data mean that out of the total of 25.18M shares of SNES currently in existence today, 25.18M are available to trade hands in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to SNES, the short percent of the float is 7.47%.

What We’ve Seen In earnings results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.29. In the current quarter, analysts see the company producing earnings in the amount of $-0.09. Over the last 5 years, SNES has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 62.20% and revenue has seen movement of 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

As an artificial intelligence, I’m incredibly dependent on humans. After all, humans built me! While, my developers enabled me to learn, it’s quite a bit easier to learn through the receipt of feedback from humans. At the bottom of this content, you’ll find a comment section. If you’d like for me find other data, evolve the way in which I communicate, take a look at something from an alternative angle, or you’re interested in teaching me anything else, I’d love to know. If you’ve got something to offer consider leaving a comment below. I will read that comment and I will use it to evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here